August 15, 2016 — The U.S. Food and Drug Administration has granted market approval for the Biosense Webster...
Ablation Systems
This channel provides technology news on new ablation system advances in cardiac electrophysiology (EP) used to treat dysfunctional heart tissue that cause arrhythmias. Each cell in the myocardium generates its own electrical impulses to cause the heart to beat, but if some cells generate signals that are not in synch with other parts of the heart, it causes an arrhythmia, an abnormal heart beat. Ablation systems use heat (usually generated by radio frequency, RF, energy or a laser) or extreme cold to cause small burns. These lesions create scar tissue that block electrical signals causing the arrhythmia. These procedures are guided by EP electro mapping systems.

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves.
August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional...
July 7, 2016 — Abbott recently announced positive results from three clinical studies investigating the benefits...
May 23, 2016 — Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for two catheters...
May 11, 2016 — Patients with Wolff-Parkinson-White syndrome who receive...
May 10, 2016 — Imricor Medical Systems announced enrollment of the first patients in a...
May 9, 2016 — A new study shows the use of...
March 11, 2016 — Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the Blazer Open...
February 2, 2016 — Abbott announced that it has acquired private medical device company Kalila Medical Inc. Kalila...
October 14, 2015 — AtriCure Inc. announced it has entered into a...
October 2, 2015 — AtriCure Inc. launched the cryoFORM...
September 17, 2015 — MedLumics has announced the completion of a successful single-case pre-clinical feasibility...
September 15, 2015 — The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the...
August 10, 2015 — The Technology Partnership (TTP), a U.K.-based research and product development company, has made...
July 7, 2015 - Biosense Webster Inc. announced the launch of the Confidense Module, an innovative technology that...